In conclusion, ESCO2 is a potential biomarker and oncogene for pan-cancer that can accurately predict the cancer patient’s prognosis in ACC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, MESO, PAAD, THYM, COAD, and READ. The gene discussed is ESCO2; the disease is cancer.